Autopsy report · NCT01856361

Ramipril for the Treatment of Oligospermia

“We did not accrue as much as anticipated and the PI (Dabaja) is no longer at Weill Cornell.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 11 months before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Weill Medical College of Cornell University

Sponsor type

University, hospital or other

Conditions

Oligospermia; Teratospermia; Asthenozoospermia; Male Infertility

Interventions

Ramipril; Placebo

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Sensory Habituation in Autism Spectrum Disorders
  “PI no longer at institution.” (63% match in meaning)
• Effects of Nitrous Oxide on Intraocular Pressure
  “PI is no longer at this institution” (63% match in meaning)
• Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis
  “PI no longer with the University” (63% match in meaning)
• Impact of Strength and Power Training on Golf Performance and Swing Biomechanics
  “PI has left the institution.” (61% match in meaning)
• Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation
  “PI no longer at this facility” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.